Amantadine's role in the treatment of levodopa-induced dyskinesia

Editorial

Robert L Rodnitzky and Nandakumar S Narayanan

Neurology, Vol.82(4), pp.288-289

01/28/2014

DOI: 10.1212/WNL.0000000000000068

PMID: 24371305

Files and links (1)

url

https://pmc.ncbi.nlm.nih.gov/articles/PMC10695663/pdf/NEUROLOGY2013550947.pdfView

Open Access

Antiviral Agents - therapeutic use

Dyskinesia, Drug-Induced - drug therapy

Humans

Levodopa - adverse effects

Parkinson Disease - drug therapy

Amantadine - therapeutic use

Antiparkinson Agents - adverse effects

Title: Subtitle: Amantadine's role in the treatment of levodopa-induced dyskinesia
Creators: Robert L Rodnitzky - From the Department of Neurology (R.L.R., N.S.N.), and Aging, Mind, and Brain Initiative (N.S.N.), University of Iowa College of Medicine, Iowa City
Nandakumar S Narayanan
Resource Type: Editorial
Publication Details: Neurology, Vol.82(4), pp.288-289
DOI: 10.1212/WNL.0000000000000068
PMID: 24371305
NLM abbreviation: Neurology
ISSN: 0028-3878
eISSN: 1526-632X
Publisher: United States
Grant note: K08 NS078100 / NINDS NIH HHS
Language: English
Date published: 01/28/2014
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984020724202771

28 Record Views